Platelet-rich plasma for foot and ankle pathologies: A systematic review

Foot and Ankle Surgery

Volumn 20, Issue 1, 2014, Pages 2-9

  Vannini, F ^a   Di Matteo, B ^a   Filardo, G ^a   Kon, E ^a   Marcacci, M ^a   Giannini, S ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

Biological enhancers; Foot and ankle; Growth factors; Platelet rich plasma; Tissue regeneration

Indexed keywords

ACHILLES TENDINITIS; ACHILLES TENDON RUPTURE; ANKLE ARTHROPLASTY; ANKLE DISEASE; ANKLE FUSION; BONE LESION; CLINICAL EFFECTIVENESS; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; FOOT DISEASE; FOOT FUSION; FOOT SURGERY; HUMAN; LEG DISEASE; MUSCULOSKELETAL SYSTEM PARAMETERS; OSTEOCHONDRAL LESION; PLANTAR FASCIITIS; PRIORITY JOURNAL; REVIEW; SYNDESMOTIC FUSION; SYSTEMATIC REVIEW; THROMBOCYTE RICH PLASMA; TISSUE REGENERATION; ANKLE; FOOT; MUSCULOSKELETAL DISEASES;

ANKLE; FOOT; HUMANS; MUSCULOSKELETAL DISEASES; PLATELET-RICH PLASMA;

EID: 84893661776     PISSN: 12687731     EISSN: 14609584     Source Type: Journal    
DOI: 10.1016/j.fas.2013.08.001     Document Type: Review

References (46)

1. Filardo G., Kon E. PRP: more words than facts. Knee Surg Sports Traumatol Arthrosc 2012, 20(9):1655-1656.
2. Foster T.E., Puskas B.L., Mandelbaum B.R., Gerhardt M.B., Rodeo S.A. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med 2009, 37(11):2259-2272.
3. Sanchez A.R., Sheridan P.J., Kupp L.I. Is platelet-rich plasma the perfect enhancement factor? A current review. Int J Oral Maxillofac Implants 2003, 18:93-103.
4. Gobbi A., Bathan L. Biological approaches for cartilage repair. J Knee Surg 2009, 22(1):36-44.
5. Cole B.J., Seroyer S.T., Filardo G., Bajaj S., Fortier L.A. Platelet-rich plasma: where are we now and where are we going?. Sports Health 2010, 2(3):203-210.
6. Boswell S.G., Cole B.J., Sundman E.A., Karas V., Fortier L.A. Platelet-rich plasma: a milieu of bioactive factors. Arthroscopy 2012, 28(3):429-439.
7. Anitua E., Andia I., Ardanza B., Nurden P., Nurden A.T. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004, 91:4-15.
8. Mishra A., Woodall J., Vieira A. Treatment of tendon and muscle using platelet-rich plasma. Clin Sports Med 2009, 28(1):113-125.
9. Soomekh D.J. Current concepts for the use of platelet-rich plasma in the foot and ankle. Clin Podiatr Med Surg 2011, 28(1):155-170.
10. Gandhi A., Bibbo C., Pinzur M., Lin S.S. The role of platelet-rich plasma in foot and ankle surgery. Foot Ankle Clin 2005, 10(4):621-637.
11. Kon E., Filardo G., Di Matteo B., Di Martino A., Marcacci M. Platelet-rich plasma in sports medicine: new treatment for tendon and cartilage lesions. Oper Tech Orthop 2012, 22(2):78-85.
12. Sánchez M., Anitua E., Azofra J., Andía I., Padilla S., Mujika I. Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. Am J Sports Med 2007, 35(2):245-251.
13. Schepull T., Kvist J., Norrman H., Trinks M., Berlin G., Aspenberg P. Autologous platelets have no effect on the healing of human achilles tendon ruptures: a randomized single-blind study. Am J Sports Med 2011, 39(1):38-47.
14. Filardo G., Presti M.L., Kon E., Marcacci M. Nonoperative biological treatment approach for partial Achilles tendon lesion. Orthopedics 2010, 33(2):120-123.
15. de Vos R.J., Weir A., van Schie H.T., Bierma-Zeinstra S.M., Verhaar J.A., Weinans H., et al. Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA 2010, 303(2):144-149.
16. de Jonge S., de Vos R.J., Weir A., van Schie H.T., Bierma-Zeinstra S.M., Verhaar J.A., et al. One-year follow-up of platelet-rich plasma treatment in chronic Achilles tendinopathy: a double-blind randomized placebo-controlled trial. Am J Sports Med 2011, 39(8):1623-1629.
17. Gaweda K., Tarczynska M., Krzyzanowski W. Treatment of Achilles tendinopathy with platelet-rich plasma. Int J Sports Med 2010, 31(8):577-583.
18. Finnoff J.T., Fowler S.P., Lai J.K., Santrach P.J., Willis E.A., Sayeed Y.A., et al. Treatment of chronic tendinopathy with ultrasound-guided needle tenotomy and platelet-rich plasma injection. PM R 2011, 3(10):900-911.
19. Owens R.F., Ginnetti J., Conti S.F., Latona C. Clinical and magnetic resonance imaging outcomes following platelet rich plasma injection for chronic midsubstance Achilles tendinopathy. Foot Ankle Int 2011, 32(11):1032-1039.
20. Monto R.R. Platelet rich plasma treatment for chronic Achilles tendinosis. Foot Ankle Int 2012, 33(5):379-385.
21. Akşahin E., Doǧruyol D., Yüksel H.Y., Hapa O., Doǧan O., Celebi L., et al. The comparison of the effect of corticosteroids and platelet-rich plasma (PRP) for the treatment of plantar fasciitis. Arch Orthop Trauma Surg 2012, 132(6):781-785.
22. Ragab E.M., Othman A.M. Platelets rich plasma for treatment of chronic plantar fasciitis. Arch Orthop Trauma Surg 2012, 132(8):1065-1070.
23. Mei-Dan O., Carmont M.R., Laver L., Mann G., Maffulli N., Nyska M. Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. Am J Sports Med 2012, 40(3):534-541.
24. Giannini S., Buda R., Vannini F., Cavallo M., Grigolo B. One-step bone marrow-derived cell transplantation in talar osteochondral lesions. Clin Orthop Relat Res 2009, 467(12):3307-3320.
25. Giannini S., Buda R., Cavallo M., Ruffilli A., Cenacchi A., Cavallo C., et al. Cartilage repair evolution in post-traumatic osteochondral lesions of the talus: from open field autologous chondrocyte to bone-marrow-derived cells transplantation. Injury 2010, 41(11):1196-1203.
26. Barrow C.R., Pomeroy G.C. Enhancement of syndesmotic fusion rates in total ankle arthroplasty with the use of autologous platelet concentrate. Foot Ankle Int 2005, 26(6):458-461.
27. Coetzee J.C., Pomeroy G.C., Watts J.D., Barrow C. The use of autologous concentrated growth factors to promote syndesmosis fusion in the Agility total ankle replacement. A preliminary study. Foot Ankle Int 2005, 26(10):840-846.
28. Bibbo C., Bono C.M., Lin S.S. Union rates using autologous platelet concentrate alone and with bone graft in high-risk foot and ankle surgery patients. J Surg Orthop Adv 2005, 14(1):17-22.
29. Filardo G., Kon E., Pereira Ruiz M.T., Vaccaro F., Guitaldi R., Di Martino A., et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: single- versus double-spinning approach. Knee Surg Sports Traumatol Arthrosc 2011, [Epub ahead of print, Dec 28].
30. Kon E., Mandelbaum B., Buda R., Filardo G., Delcogliano M., Timoncini A., et al. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy 2011, 27(11):1490-1501.
31. Filardo G., Kon E., Buda R., Timoncini A., Di Martino A., Cenacchi A., et al. Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc 2011, 19(4):528-535.
32. Kon E., Buda R., Filardo G., Di Martino A., Timoncini A., Cenacchi A., et al. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc 2010, 18(4):472-479.
33. Filardo G., Kon E., Della Villa S., Vincentelli F., Fornasari P.M., Marcacci M. Use of platelet-rich plasma for the treatment of refractory jumper's knee. Int Orthop 2010, 34(6):909-915.
34. Kon E., Filardo G., Delcogliano M., Presti M.L., Russo A., Bondi A., et al. Platelet-rich plasma: new clinical application: a pilot study for treatment of jumper's knee. Injury 2009, 40(6):598-603.
35. Spaková T., Rosocha J., Lacko M., Harvanová D., Gharaibeh A. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J Phys Med Rehabil 2012, 91(5):411-417.
36. Randelli P., Arrigoni P., Ragone V., Aliprandi A., Cabitza P. Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2-year follow-up. J Shoulder Elbow Surg 2011, 20(4):518-528.
37. Mishra A., Collado H., Fredericson M. Platelet-rich plasma compared with corticosteroid injection for chronic lateral elbow tendinosis. PM R 2009, 1(4):366-370.
38. Dragoo J.L., Braun H.J., Durham J.L., Ridley B.A., Odegaard J.I., Luong R., et al. Comparison of the acute inflammatory response of two commercial platelet-rich plasma systems in healthy rabbit tendons. Am J Sports Med 2012, 40(June (6)):1274-1281.
39. Akeda K., An H.S., Okuma M., Attawia M., Miyamoto K., Thonar E.J., et al. Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthritis Cartilage 2006, 14:1272-1280.
40. Kon E., Filardo G., Delcogliano M., Fini M., Salamanna F., Giavaresi G., et al. Platelet autologous growth factors decrease the osteochondral regeneration capability of a collagen-hydroxyapatite scaffold in a sheep model. BMC Musculoskelet Disord 2010, 11:220.
41. Marx R. Platelet rich plasma (PRP): what is PRP and what is not PRP. Implant Dent 2001, 10:225-228.
42. Marx R.E. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 2004, 62:489-496.
43. Creaney L., Hamilton B. Growth factor delivery methods in the management of sports injuries: the state of play. Br J Sports Med 2008, 42(5):314-320.
44. Tschon M., Fini M., Giardino R., Filardo G., Dallari D., Torricelli P., et al. Lights and shadows concerning platelet products for musculoskeletal regeneration. Front Biosci (Elite Ed) 2011, 3:96-107.
45. Sundman E.A., Cole B.J. Fortier LA Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma. Am J Sports Med 2011, 39(10):2135-2140.
46. Torricelli P., Fini M., Filardo G., Tschon M., Pischedda M., Pacorini A., et al. Regenerative medicine for the treatment of musculoskeletal overuse injuries in competition horses. Int Orthop 2011, 35(10):1569-1576.